Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model.

Bibliographic Details
Title: Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model.
Authors: Drishya Kurup, Delphine C Malherbe, Christoph Wirblich, Rachael Lambert, Adam J Ronk, Leila Zabihi Diba, Alexander Bukreyev, Matthias J Schnell
Source: PLoS Pathogens, Vol 17, Iss 3, p e1009383 (2021)
Publisher Information: Public Library of Science (PLoS), 2021.
Publication Year: 2021
Collection: LCC:Immunologic diseases. Allergy
LCC:Biology (General)
Subject Terms: Immunologic diseases. Allergy, RC581-607, Biology (General), QH301-705.5
More Details: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent coronavirus that has caused a worldwide pandemic. Although human disease is often asymptomatic, some develop severe illnesses such as pneumonia, respiratory failure, and death. There is an urgent need for a vaccine to prevent its rapid spread as asymptomatic infections accounting for up to 40% of transmission events. Here we further evaluated an inactivated rabies vectored SARS-CoV-2 S1 vaccine CORAVAX in a Syrian hamster model. CORAVAX adjuvanted with MPLA-AddaVax, a TRL4 agonist, induced high levels of neutralizing antibodies and generated a strong Th1-biased immune response. Vaccinated hamsters were protected from weight loss and viral replication in the lungs and nasal turbinates three days after challenge with SARS-CoV-2. CORAVAX also prevented lung disease, as indicated by the significant reduction in lung pathology. This study highlights CORAVAX as a safe, immunogenic, and efficacious vaccine that warrants further assessment in human trials.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1553-7366
1553-7374
Relation: https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009383&type=printable; https://doaj.org/toc/1553-7366; https://doaj.org/toc/1553-7374
DOI: 10.1371/journal.ppat.1009383&type=printable
DOI: 10.1371/journal.ppat.1009383
Access URL: https://doaj.org/article/937cbee1c0c04fdabbcbcd261fb4b432
Accession Number: edsdoj.937cbee1c0c04fdabbcbcd261fb4b432
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:15537366
15537374
DOI:10.1371/journal.ppat.1009383&type=printable
Published in:PLoS Pathogens
Language:English